Register for email alerts and news feeds:
This journal | BMJ Group
rss
Published Online First: 25 August 2006. doi:10.1136/gut.2006.092908
Gut 2007;56:336-341
Copyright © 2007 BMJ Publishing Group Ltd & British Society of Gastroenterology.

COELIAC DISEASE

Mutagenesis of the catalytic triad of tissue transglutaminase abrogates coeliac disease serum IgA autoantibody binding

Greg Byrne1,2, Fergus Ryan2, John Jackson1, Con Feighery1, Jacinta Kelly1,2

1 Department of Immunology, St James’s Hospital, James’s St, Dublin 8, Ireland
2 School of Biological Sciences, Dublin Institute of Technology, Kevin St, Dublin 8, Ireland

Correspondence to:
Dr Jacinta Kelly
School of Biological Sciences, Dublin Institute of Technology, Dublin 8, Ireland;Jacinta.Kelly{at}dit.ie

Background and aims: Tissue transglutaminase (tTG) is an autoantigen in coeliac disease and the related disorder, dermatitis herpetiformis. The detection of autoantibodies directed against tTG is a highly specific marker of coeliac disease; however, it is unclear if there is a role for these autoantibodies in the disease process. The aim of this study was to investigate whether the catalytic triad of tTG is targeted by coeliac disease autoantibodies.

Methods: A full-length wild-type recombinant tTG and a novel site-directed mutagenic variant lacking the catalytic triad were produced in Escherichia coli. Serum samples from 61 biopsy-proven coeliac disease and 10 dermatitis herpetiformis patients were tested for their recognition of both antigens in enzyme-linked immunosorbent assay.

Results: Although IgA autoantibodies from sera of patients with coeliac disease and dermatitis herpetiformis bound wild-type tTG well, a dramatic decrease in binding to the mutant tTG was observed with a mean reduction of 79% in coeliac disease and 58% in dermatitis herpetiformis samples. IgG anti-tTG antibodies did not show a similar pattern of reduction, with no overall difference in recognition of the wild-type or mutant tTGs.

Conclusions: These results suggest that the IgA anti-tTG response in coeliac disease and dermatitis herpetiformis is focused on the region of tTG responsible for its transamidation and deamidation reactions, whereas the IgG response may target other regions of the enzyme.

Abbreviations: tTG, tissue transglutaminase; IPTG, Isopropyl ß-D-1-thiogalactopyranoside; rpm, revolutions per minute; PBS, phosphate buffered saline

Keywords: autoimmunity; coeliac disease; transglutaminase; site-directed mutagenesis


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

This Article

Services
Citing Articles
Google Scholar
PubMed
Topic Collections
Bookmark with

Register for free content

The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Cardiology Jobs

Gastroenterology Jobs